Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure
PMID: 38778549
Source: United European Gastroenterol J
Publication date:
2025-07-24
Year:
2024
Abstract
NULL